Location History:
- 24 Lund, SE (1999 - 2003)
- Lund, SE (1992 - 2012)
Company Filing History:
2 out of 2 
1 out of 10 
1 out of 4 Years Active: 1992-2012
Title: Innovations of Gunnar Lindahl
Introduction
Gunnar Lindahl is a notable inventor based in Lund, Sweden. He has made significant contributions to the fields of microbiology and vaccine technology. With a total of 7 patents, his work focuses on developing innovative solutions to combat group B infections.
Latest Patents
One of his latest patents is a fusion protein vaccine. This invention relates to the development of a vaccine capable of conferring immunity to group B infections. It involves a novel fusion protein that comprises N-terminal region fragments of group B surface proteins, which confers immunity to invasive strains of the group B. Additionally, it pertains to an isolated nucleotide sequence encoding the fusion protein, a vector, a host cell, a vaccine, and a method for preventing or treating group B infections. Another significant patent is a vaccine composition that describes a polypeptide capable of generating a protective immune response. This composition includes a sequence that can be used in the manufacture of a medicament for vaccination against group B.
Career Highlights
Throughout his career, Gunnar Lindahl has worked with various companies, contributing his expertise to advance vaccine technology. His innovative approaches have led to the development of critical medical solutions.
Collaborations
Gunnar has collaborated with notable individuals in his field, including Margaretha Stalhammar-Carlemalm and Lars Stenberg. These collaborations have further enhanced his research and development efforts.
Conclusion
Gunnar Lindahl's contributions to vaccine technology and microbiology are significant. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the field positively.